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Epigenetic gene control is involved in mechanisms of development. Little is known about the cooperation of nuclear and chromatin events in
programmed differentiation from mouse embryonic stem cells (ESC). To address this, Oct3/4-positive ESC and differentiated progenies, Sox1-
positive neural precursor cells (NPC) and post-mitotic neurons (PMN), were isolated using a stage-selected culture system. We first investigated
global nuclear organization at the each stage. Chromocenter preexists in ESC, disperses in NPC and becomes integrated into large heterochromatic
foci in PMN, while the formation of PML bodies markedly decreases in neural differentiation. We next focused on the gene-dense MHC-Oct3/4
region. Oct3/4 gene is expressed preferentially adjacent to PML bodies in ESC and are repressed in the absence of chromocenter association in
NPC and PMN. Histone deacetylation in NPC, demethylation of lysine 4 of histone H3 (H3K4), tri-methylation of H3K27, and CpG methylation
in PMN are targeted for the Oct3/4 promoter within the region. Interestingly, di-methyl H3K4 mark is present in Oct3/4 promoter in NPC as well
as ESC. These findings provide insights into the molecular basis of global nuclear reorganization and euchromatic gene silencing in differentiation
through the spatiotemporal order of epigenetic controls.
© 2006 Elsevier Inc. All rights reserved.Keywords: Nuclear structure; Histone modification; DNA methylation; Differentiation; Embryonic stem cellsIntroduction
Cell differentiation is the programmed changes of stem cells
and progenitors, through epigenetic control of chromatin and
gene expression in nucleus (Francastel et al., 2000). It has been
suggested that the global distribution of acetylated histone H3
produces a key feature of undifferentiated stem cells (Kimura et
al., 2004; Lee et al., 2004). In this context, differentiation
originating from stem cells may be a process of converting
transcriptionally active chromatin into stably silenced chromatin
(Gasser, 2002). Genome-wide gene expression analysis revealed
that mouse stem cells such as embryonic stem cells (ESC) and
neural stem cells express approximately 40–60% of the total
genes in a genome, including a number of house-keeping and⁎ Corresponding author. Fax: +81 96 373 6804.
E-mail address: mnakao@gpo.kumamoto-u.ac.jp (M. Nakao).
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doi:10.1016/j.ydbio.2006.04.450tissue-specific genes. In contrast, most differentiated cells
express only 10–20% of the total genes (Abeyta et al., 2004).
Indeed, terminally differentiated erythroblasts have a greater
amount of condensed chromatin and a smaller sized nuclear
volume, compared to proerythroblasts (Francastel et al., 2000).
Morphologically, the chromatin structure is divided into two
heritable forms in interphase nuclei, transcriptionally active
euchromatin and inactive heterochromatin. Recent studies have
emphasized the relationship between higher ordered chromatin
structure and specific DNA/histone modifications (Jenuwein
and Allis, 2001). In euchromatic regions, histones H3/H4 are
hyperacetylated on lysine residues at the amino-terminal tail of
proteins. Conversely, heterochromatic regions are characterized
by low levels of acetylation. Further, methylation of specific
lysine residues of H3 provides complex information to the
chromatin structure (Lund and van Lohuizen, 2004). Methyl-
ation of lysine 4 of H3 (methyl H3K4) is generally observed in
euchromatic regions, while both methyl H3K9 and methyl
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dinucleotide, are found in heterochromatic regions. In addition,
modified histones and DNA are also recognized by specific
binding of chromatin factors (Lund and van Lohuizen, 2004).
Thus, epigenetic marks represent the state of chromatin and
transcriptional activity of a genomic region, which play an
essential role in developmentally coordinated gene regulation
and differentiation of stem cells. For instance, post-implantation
stage development and ESC differentiation is severely impaired
in the mutant mice lacking the histone methyltransferase or
DNA methyltransferase, although these activities are dispens-
able for ESC self-renewal (En Li et al., 1992; Okano et al.,
1999; Tachibana et al., 2002). The methylation of histone and
DNA is crucial epigenetic marks for establishment of cellular
identity during differentiation, but the molecular basis of these
findings remains unclear.
Heterochromatin structure is formed by either cis- or
trans-acting mechanisms. The cis-spreading mechanism of
heterochromatin assembly utilizes the SET domain-contain-
ing Suv39h1-mediated methylation of H3K9, followed by
recruitment of chromodomain protein HP1. HP1 then recruits
Suv39h1 to methylate neighboring histones, resulting in the
spread of heterochromatin in the pericentromeric region
(Bannister et al., 2001). In the non-pericentromeric region,
unique cis-elements, termed PRE (polycomb responsive
elements) are implicated in developmentally regulated
heterochromatin formation in Drosophila, where another
SET domain protein E(z) produces H3K27 methylation that
is recognized by Pc in the polycomb protein complex (Cao
et al., 2002). On the other hand, intranuclear positioning of a
specific gene locus relative to constitutive heterochromatin
has become one of the mechanisms for trans-acting
chromatin regulation. DNA-binding factor Ikaros is reported
to bind the promoter region of the CD2 or CD19 genes as
well as pericentromeric repeat DNA. During thymocyte
development, Ikaros and its target genes are repositioned to
the proximity of heterochromatin foci in a lineage-specific
manner (Brown et al., 1997). In addition, silenced allele of
the immunoglobulin locus preferentially locates at the
nuclear periphery in non-B lymphocytes, where stable
silencing is mediated by lamina-associated heterochromatin
(Kosak et al., 2002). Similarly, cis- and trans-types of
chromatin regulation are likely to occur in euchromatic
regions. In yeast, Sas2p acetyltransferase-dependent H4K16
acetylation and the subsequent binding of bromodomain
protein Bdf1 cause cis-spreading of euchromatin (Ladurner et
al., 2003). In mammals, several transcribed euchromatic
regions have been reported to localize around PML bodies
containing histone acetyltransferase and other proteins (Wang
et al., 2004; Ching et al., 2005). Thus, compartmentalization
of inactive or active gene loci into the specific subnuclear
positions may be a common mechanism for gene regulation
(Francastel et al., 2000).
Although the significance of epigenetic regulation in cell
differentiation has been accepted, it remains unclear how
nuclear substructure and chromatin in specific chromosomal
region are cooperatively controlled in the process of differen-tiation. The POU transcriptional factor Oct3/4 (pou5f1) gene
plays a critical role in mouse embryonic development and in
adult tissue (Nichols et al., 1998; Ramos-Mejia et al., 2005;
Hochedlinger et al., 2005). It is known that Oct3/4 expression is
restricted to pluripotent cell lineages including germ cells, early-
stage embryos and the derivative embryonic stem cells (Nichols
et al., 1998). During mouse embryogenesis or in vitro
differentiation of ESC, downregulation of the Oct3/4 gene
strongly correlates with loss of pluripotency. Further, the
abnormal expression of Oct3/4 in non-pluripotent cells results
in various developmental abnormalities, including defects in
brain patterning, hyperproliferation of epithelial dysplasia and
eventually causes tumors in multiple tissues (Ramos-Mejia et
al., 2005; Hochedlinger et al., 2005). Thus, developmental
repression of Oct3/4 must be irreversible to prevent unsched-
uled cell regulation and potential oncogenic activities. It is of
particular interest that the Oct3/4 locus is located in the most
gene-rich euchromatic region, the major histocompatibility
complex (MHC) gene cluster in mouse chromosome 17B1
(Nordhoff et al., 2001; Horton et al., 2004). The human MHC-
Oct3/4 locus conserved in chromosome 6p21.3 contains 421
genes 7.6-Mbp long; in other words, the average gene density is
one gene per 18 kbp. This gene richness is exceptionally high,
compared to the predicted average from the whole human
genome (one gene per 135 kbp). There must be a unique
mechanism to selectively repress the Oct3/4 gene within the
gene-rich euchromatic region, without affecting the chromatin
status of the adjacent genes. In the present study, we established
a lineage- and stage-specific neural differentiation of mouse
ESC in order to investigate global nuclear reorganization and
epigenetic remodeling in the MHC-Oct3/4 locus during
differentiation. Our findings provide insight into the molecular
basis of global and local remodeling in differentiating nuclei,
and the developmental significance of epigenetic marks in the
Oct3/4 locus.
Materials and methods
Cell culture and differentiation
Mouse ESC (EB3 or 46C) were maintained on feeder-free 0.1% gelatin-
coated dishes in knockout-DMEM (KO-DMEM, Gibco) supplemented with
0.3% fetal bovine serum (FBS) (Hyclone), 15% knockout-serum replacement
(KSR, Gibco), 2 mM Glutamate, 0.1 mM 2-mercaptoethanol, 1× non-essential
amino acids (NEAA, Gibco) and leukemia inhibitory factor (LIF). EB3 [Oct3/
4+/ires-bsd-pA] and 46C [Sox1+/gfp-ires-pac-pA] cells were established from parental
E14tg2a cells (Nichols et al., 1998; Niwa et al., 2002; Aubert et al., 2003). EB3
was cultured in a medium containing 5 μg/ml blastocidin S to eliminate
spontaneously differentiated cells. To induce neural differentiation of ESC, PA6
feeder cells were grown in DMEM/F12 supplemented with 15% FBS and fixed
with 4% paraformaldehyde in PBS for 20 min (Kawasaki et al., 2000). EB3 and
46C cells (1 × 103 cells/cm2) were seeded onto the fixed PA6 cells in KO-
DMEM containing 15% KSR, 2 mM glutamate, 0.1 mM 2-mercaptoethanol,
and 1× NEAA. To obtain homogeneous populations of neural cells,
differentiating 46C cells were replaced to poly-L-ornithine (Sigma) and bovine
plasma fibronectin (Sigma) coated dishes in N2B27 medium supplemented with
20 μg/ml recombinant human bFGF2 (Invitrogen) at day 6. Sox1-positive neural
precursor cells were selected under 0.5 μg/ml puromycin (Sigma) at days 8–12.
To isolate post-mitotic neurons, cells were cultured in N2B27 medium
containing 200 μM L-ascorbic acid (sigma) at day 6. At day 9, the addition of
1 μM AraC (Sigma) eliminated mitotic cells for a further 3 days.
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Western blot analysis was performed as described previously (Ichimura et
al., 2005). Antibodies used are listed in Supplementary Table 1.
Semi-quantitative RT-PCR
Total RNAs were isolated using ISOGEN (Nippon gene). For cDNA
synthesis, 5 μg of total RNAs was pretreated with DNase I (Promega) and
reverse-transcribed with oligo-dT primers and Superscript III (Invitrogen). For
PCR amplification, 1/100 volume of the cDNA products was used. Primer sets
are listed in Supplementary Table 2. All PCR amplifications were performed
within a quantitative range by adjusting cycle numbers and were normalized
with internal control β-actin.
Chromatin immunoprecipitation and quantitative real-time PCR
Chromatin immunoprecipitation analysis was performed as described
previously (Ichimura et al., 2005). Input and precipitated DNA samples were
analyzed by the SYBR green method using an ABI prism 7700 with Premix Ex
Taq™ (Perfect Real Time) reagent (Takara). PCR amplification was repeated at
least three times. Based on a standard curve of input DNA for all primers, the
fold of relative enrichment was quantified. Data were normalized with control
IgG and with PCR for β-actin promoter region. Primer sets are listed in
Supplementary Table 2.
Bisulfite genomic DNA sequencing
Genomic DNAs were purified and treated with sodium bisulfite (Fujita et al.,
1999), followed by PCR amplification with each of the specific primers using
AmpliTaq Gold (Applied Biosystems). PCR products were subcloned into
pGEM-T easy vector (Promega) and sequenced (at least 15 individual clones).
Primers used are shown in Supplementary Table 2.
Immuno-FISH (RNA and DNA)
Fluorescent in situ hybridization (FISH) analysis was performed as
described previously (Heard et al., 2001). For Immuno-DNA FISH, immuno-
fluorescence was done prior to the denaturing step in DNA-FISH. For Immuno-
RNA FISH, RNase inhibitors were added to all buffers. For preparing RNA
FISH probes, exon 1/intron 1 of the Oct3/4 gene was PCR-amplified and cloned
to pBluescript II.
Immunofluorescent analysis
Immunofluorescent analysis was performed as described previously
(Ichimura et al., 2005). Antibodies used are shown in Supplementary Table 1.
All images were obtained with an Olympus IX-90 inverted microscope using
Lumina Vision image acquisition software (version 2.0). For distance
measurements, more than 100 nuclei were analyzed three times.Results
Highly selective neural differentiation of mouse embryonic
stem cells
To investigate nuclear processes in cell differentiation, we
established an effective strategy to isolate highly homogeneous
populations of neural lineage- and stage-specific cells originat-
ing from mouse embryonic stem cells (ESC). Previous studies
have been done using embryoid body formations or treatments
with retinoid, resulting in the production of mix-lineaged
heterogeneous cell populations (Lee et al., 2004; Deb-Rinker etal., 2004). In addition, the multiple effects of retinoid showed
massive cell death or cell cycle arrest (Ross et al., 2000). In this
study, we therefore utilized a culture of ESC on formaldehyde-
fixed PA6 stromal feeder cells to reproduce an in vivo devel-
opmental program to neurogenesis (Kawasaki et al., 2000;
Barberi et al., 2003). Two genetically engineered ESC were
prepared from parental E14tg2a cells: EB3 [Oct3/4+/ires-bsd-pA]
and 46C [Sox1+/gfp-ires-pac-pA] (Fig. 1A) (Nichols et al., 1998;
Niwa et al., 2002; Aubert et al., 2003; Stavridis and Smith,
2003). EB3 cells expressed blastocidin S-resistant gene bsd
under the Oct3/4 promoter and maintained the pluripotency in
the presence of LIF (Nichols et al., 1998; Niwa et al., 2002).
Blastocidin S-selected homogeneous colonies expressed ESC-
related markers Rex1 (Fig. 1B), Oct3/4 and SSEA1 (LeX) (Fig.
1C), and alkaline phosphatase (data not shown) in approximate-
ly 95% of the ESC. To purify neural cells, we used 46C cells,
where the gfp-ires-pac-pA cassette was inserted into the early
neuroectoderm marker Sox1 gene (Aubert et al., 2003). Both
puromycin-resistant gene pac and a GFP fluorescent signal were
expressed under the Sox1 promoter. In the absence of serum and
LIF, about 70–75% of 46C cells became Sox1-GFP-positive on
the fixed PA6 cells by day 6. Using RT-PCR of lineage-specific
markers (Fig. 1B), the ES-derived Sox1-GFP-positive cells
expressed Emx2 (forebrain), En1 (midbrain and hindbrain), and
HoxB1 (hindbrain), but not non-neural markers such as MyoD
(muscle), T/bra (mesoderm), Cdx2 (trophectoderm), and CK17
(surface ectoderm).
Sox1-GFP-positive cells were further differentiated to two
neuronal cell types, proliferating neural precursor cells (NPC)
and post-mitotic neurons (PMN). To obtain mitotic NPC, Sox1-
GFP-positive cells at day 6 were placed onto poly-L-ornithine/
fibronectin-coated dishes in N2B27 medium containing bFGF
and puromycin (Ying and Smith, 2003). About 85–90% of the
resultant cells showed uniform staining of the neural progenitor
marker Nestin but not of the maturated neuronal marker TuJ1 or
the astrocyte marker GFAP by day 12 (Fig. 1D). By
neurosphere formation, the NPC produced TuJ1-positive
neurons and GFAP-positive astrocytes under the condition of
1% serum (data not shown).
The addition of ascorbic acid to Sox1-GFP-positive neural
cells in the absence of bFGF induced terminal differentiation
(Lee et al., 2000). Using AraC, post-mitotic neurons were
highly enriched by day 12 and yields 75–80% of the
populations (Fig. 1D). Therefore, three stages originating
from genetically identical cells, Oct3/4-positive ESC (pluripo-
tent), Sox1-positive NPC (multipotent), and TuJ1-positive
PMN (nullipotent) enabled us to study the molecular basis of
nuclear and epigenetic remodeling in differentiation.
Spatiotemporal changes in heterochromatin during neural
differentiation
Genome-wide gene expression analysis suggests that stem
cell differentiation may be the process of propagation of
heterochromatin (Gasser, 2002; Abeyta et al., 2004). To
investigate the overall chromatin state in ESC differentiation,
we first performed Western blot analysis using specific anti-
Fig. 1. Stage-selective neural differentiation of mouse embryonic stem cells. (A) Developmental stage-selective neural differentiation. Oct3/4-positive embryonic stem
cells (ESC) give rise to Sox1-positive early neuroectoderm cells on PA6 feeder cells. Neural precursor cells (NPC) and post-mitotic neuron (PMN) are then isolated
under indicated selections. Phase contrast images show ESC and differentiated neural cells. ESC-derived early neuroectoderm cells (day 6) express GFP from Sox1
promoter. Two culture media, KSR and N2B27, were used. AA = ascorbic acid, Ara C = cytosine arabinoside, bFGF = basic fibroblast growth factor,
BlaS = blastocidin S, LIF = leukemia inhibitory factor, and puro = puromycin. (B) Expression of differentiation markers. Reverse transcription (RT)-PCR analysis of
Oct3/4-positive ESC (day 0) and Sox1-positive early neuroectoderm cells (day 6) shows neural differentiation expressing Emx2, En1, and HoxB1. β-Actin (ActB) and
no RT reaction (−RT) are used as controls. (C and D) Immunofluorescence of stage-specific markers. Expressions of Oct3/4 (green) and SSEA1 (red) in ESC (C),
Nestin (green) in NPC, and TuJ1 (green) in PMN (D) are shown. Astrocyte marker GFAP is not found in the differentiation. DNA is counterstained with DAPI (blue).
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methylation states such as mono-methyl (Me1), di-methyl
(Me2) and tri-methyl (Me3) were tested in amino-terminal
lysine (K) of H3. Recent reports have indicated transcriptionally
active marks (acetyl H3K9/14 (H3K9/14Ac) and methyl H3K4
(H3K4Me)), and repressive marks (methyl H3K9 (H3K9Me)
and methyl H3K27 (H3K27Me)) (Jenuwein and Allis, 2001;
Peters et al., 2003). Our semi-quantitative data showed that
there were only little changes in total amounts of H3modifications in ESC, NPC, and PMN. However, chromatin-
bound forms of tri-methyl H3K9 and H3K27 tended to increase
at the stages of NPC and PMN. This result suggests that the
neural differentiation process is not dependent on a genome-
wide abundance of modified histone but coexists with
global structural change of heterochromatin in the neural
differentiation.
In cultured mouse cells, the pericentromeric satellite region
is condensed into the chromocenter in interphase and forms
358 T. Aoto et al. / Developmental Biology 298 (2006) 354–367DAPI-stained foci of constitutive heterochromatin (Bannister et
al., 2001). To observe the state of the chromocenter during
neural differentiation, we performed immunofluorescent anal-
ysis (Fig. 2A). Several DAPI-positive chromocenters were
present in undifferentiated ESC (mean number = 18.8 ± 4.2;
n = 100). Interestingly, chromocenters became dispersed to
increased numbers of small foci in NPC (mean num-
ber = 32.5 ± 5.4; n = 100), and were then integrated into
large foci in differentiated PMN (mean number = 8.8 ± 3.8;Fig. 2. Global changes of histone modifications and chromatin in neural differentiation
stage-specific markers (yellow) including SSEA1, Nestin and TuJ1 are costained. (B)
Modified H3 (green) and DAPI (blue) are shown in merged images. As described in
Developmental changes of HP1 proteins. Western blot analysis shows the expressio
amount of H3 is used as a control. HP1 marks heterochromatin in the chromocenter i
the chromocenter of PMN. (D) Distribution of transcriptionally active marks and RN
nucleoplasm (green) but not the DAPI-dense region (blue). The chromocenter is den = 100). In addition, the nuclear size markedly decreased in
differentiated cells (mean nuclear diameters: ESC = 12.9 ±
1.4 μm, PMN = 8.1 ± 2.1 μm; n = 100). However, multipotent
NPC exhibited larger nuclear sizes (mean nuclear diameter:
NPC = 22.5 ± 7.1 μm; n = 100), suggesting that differentiation
coexists with global nuclear reorganization.
To test the heterochromatic properties of the chromocenter,
we visualized various kinds of modified histone H3 in ESC and
differentiated cells (Fig. 2B). In agreement with previous. (A) Developmental changes of the DAPI-dense chromocenter. DAPI (blue) and
The chromocenter is marked with the inactive marks H3K9Me3 and H3K27Me1.
the text, the numbers and sizes of chromocenters are measured at each stage. (C)
n of HP1 isoforms at 1/27, 1/9, 1/3 and 1/1 dilutions of the cell lysates. Total
n ESC and NPC. The loss of H3K27Me1 and HP1 proteins (B and C) is found in
A polymerase II. H3K9/14Ac, H3K4Me2 and H3K4Me3 are present mostly in
void of RNA polymerase II (pol-II) (red).
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enriched with H3K9Me3 throughout neural development.
Another mark of constitutive heterochromatin, H3K27Me1,
was concentrated on the chromocenter and the nuclear
periphery in ESC and NPC. In PMN, however, this mark
showed diffuse staining and was not found in the chromocenter.
Neither H3K9Me1, H3K9Me2, H3K27Me2 nor H3K27Me3
specifically marked the chromocenter (data not shown).
To test whether HP1 isoforms (α, β and γ) are
developmentally expressed, Western blot and immunofluores-
cent analyses were undertaken using isoform-specific anti-
bodies (Ichimura et al., 2005) (Fig. 2C). HP1α appeared to be
low at the stages of ESC and PMN, while HP1β and HP1γ
were relatively maintained during differentiation. The distri-
bution of HP1β and HP1γ showed heterochromatic patterns
in ESC and NPC. As was the case with H3K27Me1, however,
both isoforms dispersed into the nucleoplasmic region in
PMN, suggesting that constituents of constitutive heterochro-
matin are developmentally regulated. In addition, the
localization of HP1 may not always depend on methyl-
H3K9 marks, since H3K9Me3 mark was localized to
chromocenter in PMN.
We next studied the state of euchromatic regions in
differentiating nuclei (Fig. 2D). The active marks were broadly
distributed in nucleoplasm and were excluded from the
chromocenter and perinuclear region. To directly determine
the active transcription sites, we carried out immunofluorescent
analysis using anti-RNA polymerase II (pol II) antibodies
(CTD4H8) in preextracted cells (Bregman et al., 1995).
Chromatin-bound pol II, which is mostly involved in transcrip-
tion, was found throughout the nucleus, except for the
chromocenter and nuclear periphery, at all three stages. In
addition, we found that Sp1, a pol II-dependent transcriptional
factor, distributed throughout the nucleoplasm except for the
chromocenter and nuclear periphery (data not shown). Collec-
tively, DAPI-stained heterochromatin globally changes in ESC
differentiation, where transcriptional activities are inhibited in
the nucleus.
Transcriptional control of the MHC-Oct3/4 locus on mouse
chromosome 17B1
We then focused on developmental remodeling of the MHC-
Oct3/4 chromosomal region in ESC differentiation. The MHC-
Oct3/4 locus spans approximately 60 kbp in the most gene-rich
cluster region on mouse chromosome 17B1 and includes
H2Q10, Oct3/4 (Pou5f1), TCF19, and Hcr genes (Fig. 3A). To
ascertain the expression of these genes, we performed semi-
quantitative RT-PCR (Fig. 3B). Oct3/4 was expressed in ESC
but repressed in differentiated cells. In contrast, H2Q10
transcript was not detected in the lineage-selective differenti-
ation, although it was PCR-amplified from mixed-lineage
differentiated embryoid bodies (data not shown). TCF19, the
gene nearest to Oct3/4, and Hcr were constantly expressed at all
three stages. We further extended our expression analysis to
500-kbp around theOct3/4 gene, using the Gene Sorter program
(http://genome.ucsc.edu/cgi-bin/hgNear) (Kent et al., 2005)(Fig. 3C). Among 17 genes spanning across this chromosomal
region, the expression of Oct3/4 in all tissues was independent
of any surrounding genes, emphasizing that Oct3/4 is
specifically regulated in the MHC-Oct3/4 locus.
To test transcriptional state of the Oct3/4 promoter, we
performed chromatin immunoprecipitation analysis combined
with real-time PCR (Fig. 3D). RNA pol-II binding to the Oct3/4
promoter was found in ESC but was completely lost in both
NPC and PMN, suggesting that transcription of Oct3/4 itself is
lost in differentiation. We then checked the involvement of HP1
in Oct3/4 silencing. HP1γ was recruited to the gene promoter at
the terminally differentiated PMN stage. The binding of HP1α
and HP1β to the promoter was not detectable (data not shown).
On the other hand, the TCF19 gene, which is 2 kbp adjacent to
the Oct3/4 gene and is expressed ubiquitously, showed
enrichment of pol-II but not HP1γ in the promoter at all three
stages, suggesting that the Oct3/4 gene is targeted for HP1γ-
mediated local heterochromatin formation in the developmental
process without affecting transcription and chromatin of
neighboring genes.
Developmental association of PML bodies and the
MHC-Oct3/4 locus
To examine the transcriptional mechanisms of the MHC-
Oct3/4 locus, we performed immuno-FISH analysis to assess
the position of the gene locus relative to subnuclear structures in
neural differentiation. PML bodies have a transcriptional role in
the nucleus and are associated with several gene-rich euchro-
matic regions (Wang et al., 2004). To address whether PML
bodies are controlled in development, we performed immuno-
fluorescent analysis (Fig. 4). Relatively large PML bodies were
present in ESC (number = 8–15 per nucleus), while small PML
bodies were found in NPC (number = 20–35 per nucleus). In
contrast, there were only a few PML bodies in the nuclei of
PMN. The majority of PML bodies were not colocalized with
DAPI-positive heterochromatin during the three stages (data not
shown). In addition, Western blot analysis showed that PML
protein was less expressed in PMN (data not shown). Thus, non-
heterochromatic PML bodies are regulated by the developmen-
tal context.
To test whether PML bodies are associated with the Oct3/4
locus, immuno-FISH analysis was done during differentiation
(Fig. 4A). We statistically analyzed the position of the Oct3/4
locus relative to the nearest PML bodies. In ESC, approximately
46% of cells (10% colocalized and 36% adjacent) showed
significant associations of Oct3/4 with PML bodies. As shown
in Fig. 4B, the use of Z axis-projected images showed the
position of two Oct3/4 loci and all the PML bodies in a single
nucleus. In addition, we performed RNA-FISH combined with
immunostaining of PML bodies. In ESC, primary Oct3/4
transcripts were found adjacent to PML bodies, but not inside
them (Fig. 4C), suggesting that the vicinity of PML bodies is
active in the transcription of this gene.
The association of the Oct3/4 locus with PML bodies was
significantly reduced in NPC and PMN (total 17% and 4% of
cells, respectively). Especially, the adjacent localizing pattern
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nuclear subcompartments including nucleoli, Cajal bodies,
Sam68 and perinucleolar bodies were not associated with the
Oct3/4 locus (data not shown), emphasizing that PML bodies
play a role in epigenetic control of this locus during
differentiation. To address this, we visualized histone acetyl-
transferase p300 in ESC nuclei (Fig. 4D). p300-containing
small foci were normally adjacent to some of PML bodies;
treatment of the cells with α-amanitin, an RNA pol II inhibitor,
induced the position of p300 to inside the PML bodies (as
shown with yellow foci in merge), suggesting that p300 isinvolved in active transcription near PML bodies. Similar
results were obtained with CBP acetyltransferase and SirT1
deacetylase (data not shown). These results suggest the
possibility that PML bodies are involved in chromatin
regulation in Oct3/4 locus.
We then studied the relationship of constitutive heterochro-
matin structures with the MHC-Oct3/4 locus in neural
differentiation (Supplementary Fig. 2). As shown in Fig. 2,
the chromocenter and nuclear periphery are enriched with
repressive heterochromatin. The Oct3/4 locus was mostly apart
from the nuclear periphery shown by lamin B during the three
Fig. 3. Transcriptional status of the MHC-Oct3/4 chromosomal region. (A) Map of the mouse MHC-Oct3/4 locus. The H2Q10 gene encodes a MHC class I receptor
and is located most upstream in the ∼60-kbp locus. The Oct3/4 gene exists in close proximity to the TCF19 gene. Downstream is the Hcr gene in a head-to-head
orientation against TCF19. There are numerous transposon-like sequences such as SINE/B2 repeats and LTR (shown with grey). (B) RT-PCR analysis of Oct3/4 and
neighboring genes in the locus. The template cDNAs at 1/9, 1/3 and 1/1 dilutions are semi-quantitatively amplified. β-Actin (ActB) and no RT reaction (-RT) are used as
controls. (C) Transcriptional independency of theOct3/4 gene within the 0.5 Mbp chromosomal region. High and low levels of mRNA expression are shown in red and
green, respectively. Gene expression profiling is extracted from the Gene Sorter program (http://genome.ucsc.edu/cgi-bin/hgNear) (Kent et al., 2005). The names of
tissues and genes are indicated on the left and at the bottom, respectively. (D) Pol-II and HP1γ binding to the Oct3/4 promoter. Chromatin immunoprecipitation was
performed with anti-pol II (CTD4H8) and anti-HP1γ antibodies, followed by real-time PCR. The TCF19 promoter is used as a control. Values are shown as
percentages relative to inputs and standard errors from three independent experiments.
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peripheral heterochromatin was constantly at 8.0–10.5%. In
addition, we checked the position of the Oct3/4 locus relative to
the DAPI-dense chromocenter. The majority of DNA signals
were not colocalized with the chromocenter at any stage
(association rate = about 5%), suggesting that Oct3/4 silencing
is not due to the tethering of this locus to constitutively inactive
heterochromatin.
Local changes of transcriptionally active marks in the
MHC-Oct3/4 locus in neural differentiation
To investigate epigenetic remodeling in the MHC-Oct3/4
locus, we performed chromatin immunoprecipitation followed
by real-time PCR. The relative enrichment of acetylation and
phosphorylation of H3/H4 in all three stages are shown as Ac-
H3 and Ac-H4, and Phos-H3S10, respectively (Supplementary
Fig. 3). The marked histones were enriched in the promoter and
gene body of Oct3/4 within the locus. Especially, these
modifications were accumulated in transcribed Oct3/4 promoter
in ESC and significantly decreased from ESC to NPC. In
addition, H2Q10 and intergenic SINE/B2 repeats (as shown in
Fig. 3A) were maintained at low levels in these modifications.
Thus, these active marks are correlated with gene activity.
Deaceylation and dephosphorylation of H3 selectively occurred
in theOct3/4 promoter region in NPC and PMN, suggesting that
Oct3/4 silencing is due to local epigenetic remodeling.Next, we checked the status of the methylation of H3K4
(H3K4Me1, H3K4Me2, H3K4Me3) (Fig. 5A). Especially, di- and
tri-methylation of H3K4 play central roles in ordered recruitment
of the acetyltransferase and transcriptional preinitiation complex
(Lund and von Lohuizen, 2004). H3K4Me3 strikingly marked
actively transcribed Oct3/4 gene, since this mark disappeared in
the Oct3/4 promoter in NPC. On the other hand, H3K4Me2 was
unexpectedly present in the Oct3/4 promoter in NPC where the
gene was transcriptionally silent, as well as in ESC where it was
actively transcribed. In post-mitotic neurons, H3K4Me2 was
found at very low levels. It is of interest that H3K4Me2 persists in
the transcriptionally inactiveOct3/4 promoter inmultipotentNPC
and is erased after the terminal differentiation. Thus, active marks
in theOct3/4 promoter region are lost at each differentiation stage,
and epigenetic remodeling of Oct3/4 progresses even after the
gene is silenced in NPC.
Local changes of repressive marks in the MHC-Oct3/4 locus in
neural differentiation
To further investigate transcriptional repression of the Oct3/4
gene, we examined repressive heterochromatin landmarks,
methylation of H3K9 and H3K27, in ESC and differentiating
cells (Fig. 5B).We used 2× branch-type antibodies againstmethyl
H3 for chromatin immunoprecipitation analysis (Peters et al.,
2003). Among these inactive marks, H3K27Me3 specifically
appeared in the core promoter region of theOct3/4 gene in PMN,
Fig. 4. Developmental regulation of PML bodies and theMHC-Oct3/4 locus. (A) Immuno-FISH analysis of the Oct3/4 locus relative to PML bodies. Localization of
the Oct3/4 locus (green and arrows) and PML bodies (red) is shown in the merged images. The positions of the Oct3/4 locus relative to the nearest PML bodies are
statistically analyzed: colocalized, adjacent (less than 2 μm between the locus and the bodies) and non-associated (more than 2 μm between the two). The Oct3/4 locus
is significantly adjacent to the PML bodies in ESC (as indicated by an asterisk). More than 100 cells at each stage were used to show the means and standard errors. (B)
Z axis projected image. Both alleles of theMHC-Oct3/4 locus and all PML bodies are shown. (C) RNA-FISH analysis. TheOct3/4 transcript (green) is almost adjacent
to PML bodies (red) in the Z axis projected image. DNA fragment for exon 1/intron 1 of Oct3/4 was used as a probe. (D) Transcription-dependent positioning of p300
histone acetyltransferase near PML bodies in ESC. p300-containing foci (red) are normally adjacent to PML bodies (green). The treatment of cells with α-amanitin,
RNA Pol II inhibitor, redistributes p300 to inside the PML bodies. (C and D) Active transcription is likely to occur adjacent to PML bodies, but not in the PML bodies
in ESC.
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formed at the terminal differentiation stage. In addition to
H3K9Me2/Me3 and H3K27Me1 (Fig. 5B), H3K9Me1 and
H3K27Me2 were not enriched in the locus (data not shown).
Tri-methylation of H3K27 did not take place in the unexpressed
H2Q10 gene. Thus, H3K27Me3-mediated repressive chromatin
is specific to the Oct3/4 gene and is not global in the locus.
Oct3/4 promoter-targeted DNA methylation in post-mitotic
neuron
Finally, we investigated CpGmethylation of the entireMHC-
Oct3/4 locus at each developmental stage (Fig. 6). Gene-specific
DNA methylation is one of the stable silencing mechanisms that
little affects chromatin and transcription of neighboring genes
(Lund and van Lohuizen, 2004; Irvine et al., 2002). We carried
out bisulfite genomic sequencing to demonstrate the methylation
status at 96 CpG sites in the 16 regions. The upstream region of
theOct3/4 gene (sites 8–13) was almost free of CpGmethylation
in ESC. Intriguingly, this hypomethylation status was main-
tained in NPC, where the Oct3/4 gene was not expressed. In
terminally differentiated neurons, the Oct3/4 promoter wassignificantly hypermethylated. At any stage, expressed TCF19/
Hcr (site 16) was hypomethylated, and unexpressedH2Q10 also
lacked CpGmethylation (site 1). Collectively, DNAmethylation
as well as H3K27 tri-methylation is selectively targeted to the
Oct3/4 promoter within the chromosomal locus at the late
differentiation stage.
Discussion
Nuclear and chromatin reorganization in differentiation from
ESC to progenies
In the present study, we have provided insights into the
molecular basis of global and local remodeling in differentiating
nuclei, and the significance of epigenetic marks in the Oct3/4
locus in ESC differentiation. The culture system of Oct3/4-
positive ESC to Sox 1-positive NPC and then post-mitotic PMN
was established to investigate a differentiating process (summa-
rized in Fig. 7). Pluripotent ESC is characterized by the presence
of RNA pol II and active marks such as acetyl H3/H4, di- and tri-
methyl H3K4, and phosphorylated H3S10 in the transcribed
Oct3/4 locus that was associated with non-heterochromatic PML
Fig. 5. Developmental stage-specific active and repressive marks in the Oct3/4 promoter in neural differentiation. (A) The distribution of mono-, di-, and tri-methyl
H3K4 in the MHC-Oct3/4 locus. Chromatin immunoprecipitation followed by real-time PCR was performed with anti-modified histone antibodies. From three
independent experiments, mono- (blue), di- (red), and tri- (black) methylation of H3K4 is shown as relative enrichment folds and standard errors. Positions of each site
correspond to the locus map. (B) The distribution of methyl H3K9/K27 in theMHC-Oct3/4 locus in neural differentiation. H3K9Me2 (blue), H3K9 Me3 (red), H3K27
Me1 (black), and H3K27 Me3 (light blue) are shown. The Oct3/4 core promoter is specifically marked with H3K27 Me3 in PMN.
363T. Aoto et al. / Developmental Biology 298 (2006) 354–367bodies. In multipotent NPC, RNA pol II, acetyl H3/H4 and tri-
methyl H3K4 aswell as the PML associationmostly disappear in
the silenced Oct3/4 promoter. It is interesting that the active
mark of di-methyl H3K4 alone is maintained in the genepromoter at this stage. In nullipotent PMN, the Oct3/4
promoter is particularly marked with tri-methyl H3K27 and
HP1γ, together with de novo CpG methylation, suggesting
that more profound repression occurs after transcriptional
Fig. 6. CpG methylation in theMHC-Oct3/4 locus in terminal differentiation stage. Methylation status at 96 CpG dinucleotides in the locus was analyzed by bisulfite
genomic sequencing. The PCR-amplified sites (1 to 16) are indicated on the map. The upstream region of the Oct3/4 gene (sites 8–13) is selectively methylated in
PMN. Open circle, unmethylated CpG; closed circle, methylated CpG.
364 T. Aoto et al. / Developmental Biology 298 (2006) 354–367silencing at the NPC stage. From the viewpoint of a global
subnuclear structure, the tri-methyl H3K9-positive heterochro-
matic chromocenter, the cluster of pericentromeric heterochro-ig. 7. Model of global nuclear organization and local epigenetic marks at the MHC-Oct3/4 locus in embryonic stem cell differentiation. Global nuclear structure in
eural differentiation is shown in the upper part. The chromocenters are preformed in embryonic stem cells (ESC), dispersed into small foci in neural precursor cells
PC), and become integrated into large foci in post-mitotic neurons (PMN). In addition, PML bodies, which are associated with histone acetyltransferases, are present
ESC and NPC, and decrease in the terminal differentiation. The specific association of theMHC-Oct3/4 locus with PML bodies is seen in ESC, suggesting that PML
odies are involved in chromatin of Oct3/4 gene. In the lower part, chromatin status of the Oct3/4 gene promoter is shown: orange for ESC, pink for NPC, and yellow
r PMN. During neural differentiation,Oct3/4 gene becomes transcriptionally inactive in NPC, together with the loss of active chromatin marks except for H3K4Me2.






Inmatin regions, becomes integrated into large foci at the PMN
stage. In contrast, the formation of PML bodies markedly
decreases during neural differentiation. Thus, our data indicate
365T. Aoto et al. / Developmental Biology 298 (2006) 354–367that (1) phased differentiation progresses globally and locally
in the nuclei, and (2) nuclear and epigenetic marks of the
MHC-Oct3/4 locus represent developmental stages in ESC
differentiation.
Heterochromatin formation seems to be crucial step for exit
from the pluripotent states (Lee et al., 2004). On the other hand,
genome-wide euchromatin formation is involved in nuclear
reprogramming activity of ESC (Kimura et al., 2004). Both
types of chromatin structure significantly contribute to stem cell
differentiation. As shown in Fig. 2, the transcriptionally inactive
chromocenter is integrated into several large foci in terminally
differentiated neurons. A similar observation was recently
reported in muscle cells (Brero et al., 2005), suggesting that
chromocenter integration is a common mechanism in terminal
differentiation. It is interesting that the chromocenter transiently
dispersed into small multiple foci at the NPC stage, suggesting
that pericentromeric heterochromatin regions are actively
reorganized prior to terminal differentiation.
Hsieh et al. reported that adult neural stem cells produce
two distinct patterns of global histone acetylation: astrocytes
and oligodendrocytes undergo global deacetylation of histones
while neuronally differentiated cells maintain global acetyla-
tion (Hsieh et al., 2004). In our study, there were no
significant differences in the total amounts of modified
histones in ESC and neurally differentiated cells. However,
chromatin-bound forms with tri-methylation of H3K9 and
H3K27 appeared to increase at the NPC and PMN stages
(Supplementary Fig. 1). Although the chromocenter is formed
with inactive constituents such as H3K9Me3, H3K27Me1 and
HP1 in ESC and NPC, the H3K9Me3-enriched chromocenter
lacked H3K27Me1 and HP1 in neurons, suggesting that the
same histone mark has distinct roles in a cell type-dependent
manner. H3K27Me1 and HP1 may function for initiation
rather than maintenance of pericentromeric heterochromatin
during neural differentiation. At the PMN stage, HP1 is likely
to be relocalized into euchromatin regions to form a new type
of facultative heterochromatin, as HP1γ appeared in the Oct3/
4 promoter in neurons.
The Oct3/4 locus was found in the close vicinity of PML
bodies in ESC but not in NPC and PMN (Fig. 4), suggesting that
the association of the Oct3/4 locus to the nearest PML bodies
provides a dynamic equilibrium for activation and repression of
the Oct3/4 gene. To support this notion, both histone acetylases
and deacetylaseswere concentrated in the vicinity of PMLbodies
in ESC (Fig. 4 and data not shown). Moreover, histone
acetyltransferase such as p300 and CBP were normally found
near the bodies where active transcriptional reactions occur.
Additionally, neural differentiation reduced the formation of
PML bodies, suggesting their involvement in the process of cell
differentiation. Collectively, both global and local reorganization
of nuclear structures occurs during the phases of differentiation.
Euchromatic gene regulation of the MHC-Oct3/4 locus in
differentiation
Like the MHC-Oct3/4 locus, most gene-dense euchromatin
regions display an open configuration irrespective of theexpression state of each gene (Gilbert et al., 2004). The Oct3/4
gene is selectively targeted for inactivation within the
euchromatic locus, through spatiotemporally controlled loss
of active marks and gain of repressive marks (Fig. 5).
Numerous reports have shown the biological significance of
transcriptional control of the Oct3/4 gene. At a cellular level,
just a 50% increase or decrease of the Oct3/4 level altered the
differentiation fate of ESC (Niwa et al., 2000). Based on
nuclear transfer experiments, production of cloned animals
from several somatic cells depends on the expression of the
Oct3/4 gene (Boiani et al., 2002). Interestingly, multipotent
neural stem cells have been reported to revert to pluripotent
ESC-like cells (Clarke et al., 2000). In contrast, the nuclei from
post-mitotic neurons are the most resistant to reprogram
experimentally (Yamazaki et al., 2001). Further, nuclear
reprogramming and Oct3/4 reexpression requires the Brg1-
containing SWI/SNF chromatin remodeling complex (Hansis et
al., 2004), and the Oct3/4 promoter was selectively demethy-
lated during the nuclear reprogramming (Simonsson and
Gurdon, 2004). Thus, epigenetic control of the Oct3/4 gene
within the MHC-Oct3/4 locus is essential for nuclear remodel-
ing during ESC differentiation and somatic de-differentiation.
These suggest that the Oct3/4 gene has its own program of
methylation and demethylation at CpG sites, as was previously
reported in other genes (Kremenskoy et al., 2003).
Prior to DNA methylation, unexpressed Oct3/4 genes are
marked with H3K4Me2 in NPC, suggesting that this mark
prevents further repressive modifications in the gene locus. The
methyl H3K4 mark in unexpressed genes has also been reported
in the β-globin locus (Schneider et al., 2004). The loss of
H3K4Me2 coexists with the appearance of DNA methylation,
H3K27Me3 and HP1γ in the Oct3/4 promoter in PMN. Among
these repressive marks, CpG methylation is thought to be a long
lasting and stable mark to fix the terminally differentiated state
of PMN. Thus, the Oct3/4 locus is converted into more
restricted transcriptional potential step by step. The stage-
specific epigenetic marks may directly reflect the difference
between multipotent and nullipotent cells (Clarke et al., 2000;
Yamazaki et al., 2001).
Coordinately regulated gene clusters have been reported to
coexist with chromocenter or nuclear periphery when they are
transcriptionally inactive (Brown et al., 1997; Francastel et
al., 2000; Kosak et al., 2002); however, the Oct3/4 locus is
not associated with the chromocenter or nuclear periphery for
transcriptional repression (Supplementary Fig. 2). In terminal
differentiation, not only CpG methylation but also polycomb-
associated tri-methyl H3K27 was found in the core promoter
region of the Oct3/4 gene. Similarly, both polycomb proteins
and H3K27Me3 were found in the very narrow 5′ region of
the Ubx gene (Cao et al., 2002), suggesting that the polycomb
group complex converts target genes to a repressive state,
but without affecting the surrounding genomic regions.
Additionally, among HP1 family proteins, HP1γ directly
inhibits general transcription factors such as TAFII130
(Vassallo and Tanese, 2002). The fluorescence recovery
after photobleaching analysis showed the dynamic movements
of both HP1 and polycomb proteins in vivo (Cheutin et al.,
366 T. Aoto et al. / Developmental Biology 298 (2006) 354–3672003; Ficz et al., 2005), suggesting that they actively function
in transcriptional repression as well as heterochromatin
formation. Thus, local heterochromatin formation causes
specific repression of Oct3/4 within the gene-dense euchro-
matin region. In summary, these findings indicate that nuclear
and epigenetic remodeling of the MHC-Oct3/4 locus marks
developmental phases in ESC differentiation.
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